Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma

Por Sicong Zhu, Xuelian Huang, Kelin Zhang, Wenliang Tan, Zhirong Lin, Qing He, Yajin Chen, Changzhen Shang
Publicado em 2019-12-01

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma

Por Hongkai Zhuang, Hongkai Zhuang, Bo Chen, Chenwei Tang, Chenwei Tang, Xinming Chen, Wenliang Tan, Wenliang Tan, Lei Yang, Lei Yang, Zhiqin Xie, Zhiqin Xie, Xiaowu Ma, Xiaowu Ma, Qingbin Wang, Qingbin Wang, Chuanzhao Zhang, Changzhen Shang, Changzhen Shang, Yajin Chen, Yajin Chen
Publicado em 2022-05-01

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]

Por Wenliang Tan, Xuan Luo, Wenda Li, Jinyi Zhong, Jun Cao, Sicong Zhu, Xianqing Chen, Rui Zhou, Changzhen Shang, Yajin Chen
Publicado em 2022-06-01

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway

Por Lei Yang, Wenliang Tan, Yingcheng Wei, Zhiqin Xie, Wenxin Li, Xiaowu Ma, Qingbin Wang, Huilong Li, Ziyu Zhang, Changzhen Shang, Yajin Chen
Publicado em 2022-05-01